Coherus Biosciences, Inc. (CHRS)

Trade CHRS now with
4/15/2020 1:11:27 AM Coherus Prices $200 Mln Convertible Senior Subordinated Notes Offering
1/13/2020 8:37:28 AM Coherus BioSciences Enters Licensing Agreement With Innovent Biologics
9/20/2019 9:36:46 AM Coherus Says Compensation Committee Of Board Grant 7 New Employees Options
8/22/2019 9:33:41 AM LiveWire Ergogenics Reports New Employment Inducement Grants
7/29/2019 8:58:41 PM Coherus BioSciences Reports Victory In Pegfilgrastim Patent Dispute
7/19/2019 9:35:11 AM Coherus BioSciences Says Granted Five New Employees Options
6/21/2019 9:33:55 AM Coherus BioSciences Announces Grant Of Stock Options
1/25/2019 1:26:47 PM Coherus BioSciences Announces Filing Of Patent Infringement Suit Against Amgen
1/25/2019 8:01:51 AM Coherus BioSciences Executes Settlement Agreements With AbbVie
1/14/2019 9:33:06 AM Coherus BioSciences Reports Inducement Grants To Three New Employees
1/7/2019 9:26:07 AM Coherus BioSciences Enters $75 Mln Senior Secured Credit Facility Agreement With Healthcare Royalty Partners
1/2/2019 9:31:46 AM Coherus BioSciences Names Darlene Horton Chief Medical And Regulatory Affairs Officer
11/30/2018 9:31:11 AM Coherus BioSciences Announces Apexus Contract Deal For 340B Hospitals And Clinics, And Q-Code Issuance From CMS
11/8/2018 4:03:38 PM Coherus BioSciences Q3 Loss/share $0.87 Vs. Loss $1.09 Year Ago
9/21/2018 8:03:50 AM Coherus BioSciences Announces New Employment Inducement Grants
8/8/2018 4:06:02 PM Coherus BioSciences Q2 Loss/share $0.68 Vs. Loss $1.08 Year Ago